Do bacterial curli amyloids cross the blood-brain barrier to directly seed α-synuclein aggregation in humans?

Mechanistic Hypotheses: Curli Amyloid Trans-BBB Seeding of α-Synuclein Aggregation

Hypothesis 1: LRP1-Mediated Curli Transcytosis Across the BBB

Title: LRP1 receptor mediates curli amyloid transcytosis

Mechanism: Curli fibrils (primarily CsgA monomers with conserved β-solenoid structure) bind to the low-density lipoprotein receptor-related protein 1 (LRP1) on brain microvascular endothelial cells. LRP1-mediated endocytosis packages curli into vesicles that traffic across the endothelial cytoplasm, releasing curli into the brain parenchyma via exocytosis at the abluminal membrane. Released curli directly templating α-synuclein (SNCA) monomer misfolding via cross-β-sheet complementarity.

Key Evidence:

• E. coli curli accelerate α-synuclein aggregation and dopaminergic neurodegeneration in M83 mice (PMID: 31101651)
• LRP1 mediates transcytosis of other amyloid species (Aβ40, α-synuclein oligomers) across BBB (PMID: 23702984)

Testable Prediction: siRNA knockdown of LRP1 in human iPSC-derived brain microvascular endothelial cells (BMVECs) will reduce transwell transport of purified FITC-labeled curli fibrils by >70% compared to non-targeting controls.

Target Gene/Protein: LRP1 (LIPR1_HUMAN)

Hypothesis 2: Cross-Seeding at the Neurovascular Unit via C3b Opsonization

Title: Complement C3 deposits on curli enabling BBB crossing

Mechanism: Systemic curli activates the classical complement cascade via C1q binding to curli fibrils (similar to Aβ recognition), leading to C3b opsonization. C3b-coated curli engages CR3 (CD11b/CD18) on infiltrating monocytes and neutrophils, hitchhiking across a compromised BBB. Alternatively, C3b binds CR3 on brain endothelial cells, triggering LRP1-independent transmigration. Within the brain, C3b-curli complexes directly nucleate α-synuclein fibrillization.

Key Evidence:

• Curli activate complement factor C3 in vitro and in vivo (PMID: 31249567)
• C3 deficiency attenuates α-synuclein pathology in MOG35-80-immunized mice (PMID: 31953283)

Testable Prediction: C3 knockout mice colonized with curli-producing E. coli will show reduced brain parenchymal curli (measured by RT-QuIC) and attenuated α-synuclein seeding compared to WT colonized mice.

Target Gene/Protein: Complement C3 (CO3_HUMAN)

Hypothesis 3: Bacterial Outer Membrane Vesicles Carry Curli Across the BBB

Title: Curli-vesicle complexes penetrate BBB intact

Mechanism: Curli fibers become incorporated into or

Critical Evaluation: Curli-βBB Seeding Hypotheses

Hypothesis 1: LRP1-Mediated Transcytosis

Strongest Specific Weakness: Physical Implausibility of Transcytosis

LRP1 is a caveolae-mediated transcytosis receptor with well-documented size constraints. Its documented ligands are typically soluble proteins <100 kDa with specific structural motifs (apolipoprotein E, α2-macroglobulin, lactoferrin). Curli fibrils are macromolecular amyloids—typically microns in length, with a cross-β-sheet architecture that self-propagates. The assumption that intact curli fibrils undergo vesicular transcytosis lacks any biophysical precedent. Endothelial caveolae have documented upper size limits (~200 nm diameter) for transcytosed cargo (Tuma & Hubbard, Physiol Rev 2003; PMID: 14526099). This is not a minor mechanistic detail—it is a fundamental thermodynamic and geometric barrier.

Counter-Evidence and Complications

Size constraint: The Aβ oligomers and α-synuclein oligomers cited in PMID: 23702984 are nanoscale (typically 2-20 nm). No study demonstrates LRP1 transcytosis of micron-scale amyloid fibrils. This is an unsupported extrapolation across 2-3 orders of magnitude in cargo size.

Missing direct binding evidence: The hypothesis requires curli-CsgA to bind LRP1 with affinity sufficient for endocytosis. To my knowledge, no study has demonstrated direct biochemical binding between purified CsgA/CsgB and LRP1. The cited LRP1 evidence involves Aβ and α-synuclein oligomers—proteins with established LRP1-binding domains. Curli lacks predicted LRP1 recognition sequences.

Alternative explanation for the mouse data (PMID: 31101651): The M83 mouse study shows accelerated α-synuclein pathology after E. coli infection, but this could reflect infection-induced neuroinflammation causing general BBB disruption and secondary seeding from endogenous α-synuclein. The study does not isolate curli as the active agent or demonstrate its presence in brain parenchyma.

Pointed Question

**You propose that intact curli fibrils undergo LRP1-mediated transcytosis. By what quantitative mechanism do you propose micron-scale rigid cross-β-sheet fibrils are packaged into ~70-100 nm vesicles, trafficked across the

Domain Expert Assessment: Curli Trans-BBB Seeding Hypotheses

1. Hypotheses with Highest Translational Potential

Rather than ranking the two hypotheses presented, I would propose a restructured third hypothesis that synthesizes their strongest elements while circumventing the most critical translational barrier. This hybrid hypothesis has the highest near-term clinical feasibility.

Ranked by Translational Potential:

Tier 1 — Highest Feasibility

Hypothesis 3 (Hybrid): Gut-to-Brain Propagation via the Enteric Nervous System with Secondary BBB Compromise

This is not the Theorist's explicit framing, but it is the logical translational synthesis of their two hypotheses. The mechanism proceeds as follows:

Gut dysbiosis → elevated curli production in the intestinal lumen

Curli locally seeds α-synuclein misfolding in enteric neurons (mechanistically established in Chen et al., Acta Neuropathologica Communications, 2022)

Misfolded α-synuclein propagates retrograde via the vagus nerve to the dorsal motor nucleus of the vagus (DMNV), a site of early α-synuclein pathology in PD and incidental LB pathology in aging

Secondary brainstem neuroinflammation then compromises BBB integrity — including downregulating LRP1 expression at the neurovascular unit — allowing further peripheral inflammatory signals or fragmented curli to enter

Why this bypasses the Skeptic's central challenge: It does not require intact curli fibrils to undergo transcytosis. The physical barrier becomes irrelevant because the propagation vector is neural, not vascular. The Theorist's LRP1 hypothesis is repurposed as a downstream event — a consequence of neuroinflammation rather than the primary seeding mechanism.

Tier 2 — Mechanistically plausible but higher risk

Hypothesis 1 (Modified): LRP1-Mediated Transcytosis of Curli Oligomeric Fragments

The Skeptic's size constraint argument (caveolae ~200 nm upper limit) is largely correct for intact curli fibrils, which are microns in length. However, the literature on amyloid transcytosis increasingly distinguishes between fibrils and oligomeric intermediates. If curli fibrils undergo mechanical shearing, proteolytic processing in circulation, or partial depolymerization by the endothelial cellular machinery, the resulting nanoscale fragments (10-50 nm) could be LRP1-compatible. This reframes the hypothesis without abandoning the core LRP1 mechanism.

Tier 3 — Lowest translational feasibility (as stated)

Hypothesis 2 (Complement-mediated crossing): The C3b opsonization mechanism is mechanistically interesting but faces the additional complexity that complement activation at the BBB requires prior endothelial dysfunction. It is more plausibly a secondary amplifier of an already-initiated process than a primary seeding mechanism. Its translational potential lies in identifying patients with elevated complement activation as a biomarker enrichment strategy.

2. Current Clinical Evidence, Safety Considerations, and Patient Population Fit

Hypothesis 3 (Gut